{"product_id":"3d-cell-culture-market-by-product-hydrogels-ecm-hanging-drop-bioreactor-microfluidics-magnetic-levitation-application-cancer-stem-cell-tissue-engineering-end-user-pharma-biotech-research-region-global-forecast-to-2028","title":"3D Cell Culture Market by Product (Hydrogels, ECM, Hanging Drop, Bioreactor, Microfluidics, Magnetic Levitation), Application (Cancer, Stem Cell, Tissue Engineering), End User (Pharma, Biotech, Research), Region - Global Forecast to 2028","description":"\u003cp\u003e3D Cell Culture Market by Product (Hydrogels, ECM, Hanging Drop, Bioreactor, Microfluidics, Magnetic Levitation), Application (Cancer, Stem Cell, Tissue Engineering), End User (Pharma, Biotech, Research), Region - Global Forecast to 2028\u003c\/p\u003e\n\n\u003cp\u003eThe global 3D cell culture market size is projected to reach USD 2.5 billion by 2028 from USD 1.3 billion in 2023, at a CAGR of 14.6% during the forecast period. Factors such as increased adoption of 3D cell culture coupled with increased funding for 3D cell culture research is driving the market growth.\u003c\/p\u003e \n\n\u003cp\u003e“The scaffold-based 3D cell culture product segment accounted for the highest growth rate in the 3D cell culture market, by drug class, during the forecast period”\u003c\/p\u003e\n\n\u003cp\u003eBased on product, the 3D cell culture market is segmented into scaffold-based 3D cell cultures, scaffold-free 3D cell cultures, microfluidics-based 3D cell cultures, and magnetic \u0026amp; bioprinted 3D cell cultures. The scaffold-based 3D cell cultures segment accounted for the largest share in 2022. Rising demand for hydrogels across various pharmaceutical industries is likely to have positive impact on the growth of scaffold-based 3D cell culture market.\u003c\/p\u003e \n\n\u003cp\u003e“Cancer and Stem cell research segment accounted for the largest share of the application segment in 2022.”\u003c\/p\u003e\n\n\u003cp\u003eBased on application, the market is segmented into cancer \u0026amp; stem cell research, drug discovery \u0026amp; toxicology testing, and tissue engineering \u0026amp; regenerative medicine. Cancer \u0026amp; stem cell segment research accounted for the largest market share in the market in 2022. The increasing prevalence of cancer and significant funding initiatives for cancer research from the government and the private sector are major factors driving the growth of this application segment.\u003c\/p\u003e \n\n\u003cp\u003e“Asia Pacific region is likely to grow at a faster pace.”\u003c\/p\u003e\n\n\u003cp\u003eThe 3D cell culture market is segmented into Europe, Asia Pacific, North America, latin America and Middle East and Africa. The APAC market is expected to be the fastest-growing regional segment during the forecast period due the presence of favorable regulatory guidelines, government support for cell culture-based vaccine production, low manufacturing costs, and the growing focus of global market players on emerging Asian countries.\u003c\/p\u003e\n\n\u003cp\u003eThe primary interviews conducted for this report can be categorized as follows:\u003c\/p\u003e\n\n\u003cp\u003eBy Respondent: Supply Side- 70%, and Demand Side - 30%\u003c\/p\u003e\n\n\u003cp\u003eBy Designation (Supply Side): Managers - 45%, CXOs \u0026amp; Directors - 30%, Executives- 25%\u003c\/p\u003e\n\n\u003cp\u003eBy Region: North America -40%, Europe -25%, Asia-Pacific -20%, Latin America -10%, and Middle East and Africa -5%\u003c\/p\u003e\n\n\u003cp\u003eLists of Companies Profiled in the Report:\u003c\/p\u003e\n\n\u003cp\u003eThermo Fisher Scientific, Inc. (US)\u003c\/p\u003e\n\n\u003cp\u003eMerck KGaA (Germany)\u003c\/p\u003e\n\n\u003cp\u003eCorning Incorporated (US)\u003c\/p\u003e\n\n\u003cp\u003eLonza (Switzerland)\u003c\/p\u003e\n\n\u003cp\u003eTecan Trading AG (Switzerland)\u003c\/p\u003e\n\n\u003cp\u003eAvantor, Inc.(US),\u003c\/p\u003e \n\n\u003cp\u003eREPROCELL Inc. (Japan)\u003c\/p\u003e \n\n\u003cp\u003e3D Biotek LLC. (US)\u003c\/p\u003e\n\n\u003cp\u003eS-BIO, Vaupell Holdings Inc. (US)\u003c\/p\u003e\n\n\u003cp\u003eAdvanced BioMatrix, Inc. (US)\u003c\/p\u003e\n\n\u003cp\u003eUPM Biomedicals (Finland)\u003c\/p\u003e\n\n\u003cp\u003eSYNTHECON, INCORPORATED (US)\u003c\/p\u003e\n\n\u003cp\u003eInSphero (Switzerland)\u003c\/p\u003e \n\n\u003cp\u003eEmulate, Inc. (US)\u003c\/p\u003e\n\n\u003cp\u003eCN Bio Innovations Ltd. (UK)\u003c\/p\u003e\n\n\u003cp\u003eSynVivo, Inc.(US)\u003c\/p\u003e\n\n\u003cp\u003eKirkstall Ltd. (UK)\u003c\/p\u003e\n\n\u003cp\u003eLena Biosciences (US)\u003c\/p\u003e\n\n\u003cp\u003eTissUse GmbH (Germany)\u003c\/p\u003e\n\n\u003cp\u003eCellendes GmbH (Germany)\u003c\/p\u003e\n\n\u003cp\u003eGreiner Bio-one International GmbH (Germany)\u003c\/p\u003e\n\n\u003cp\u003eAMSBIO (UK)\u003c\/p\u003e\n\n\u003cp\u003eMIMETAS B.V.(Netherlands)\u003c\/p\u003e\n\n\u003cp\u003ePromocell GmbH (Germany)\u003c\/p\u003e\n\n\u003cp\u003eNanofiber Solutions (US)\u003c\/p\u003e\n\n\u003cp\u003eResearch Coverage:\u003c\/p\u003e\n\n\u003cp\u003eThis report provides a detailed picture of the 3D cell culture market. It aims at estimating the size and future growth potential of the market across different segments, such as product, application, end user and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.\u003c\/p\u003e\n\n\u003cp\u003eKey Benefits of Buying the Report:\u003c\/p\u003e\n\n\u003cp\u003eThe report will help market leaders\/new entrants by providing them with the closest approximations of the revenue numbers for the overall 3D cell culture market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.\u003c\/p\u003e\n\n\u003cp\u003eThe report provides insights on the following pointers:\u003c\/p\u003e \n\n\u003cp\u003eAnalysis of key drivers (high focus on developing alterantives to animal testing, greater adoption of personalized medicine, increased government support and funding, increased academia-research collabrations), restraints (high cost of implementing 3D cell culture technologies, lack of widely accepted or single standardization in 3D cell culture), opportunities (emergence of microfluidic based 3D cell culture), and challenges (lack of consistency in 3D cell culture products, high dependency on plastic waste disposals and consumables) influencing the growth of 3D cell culture market.\u003c\/p\u003e\n\n\u003cp\u003eProduct Development\/Innovation: Detailed insights on newly launched products of the 3D cell culture market.\u003c\/p\u003e\n\n\u003cp\u003eMarket Development: Comprehensive information about lucrative markets – the report analyses the 3D cell culture market across varied regions.\u003c\/p\u003e \n\n\u003cp\u003eMarket Diversification: Exhaustive information about new services, untapped geographies, recent developments, and investments in the 3D cell culture market.\u003c\/p\u003e \n\n\u003cp\u003eCompetitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players . Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Corning Incorporated (US), Lonza (Switzerland), and Avantor Inc. (US)  and  among others in the 3D cell culture market.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"July, 2023 \/ 237 Pages \/ MCW16231174","offer_id":47647274434866,"sku":null,"price":5940.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/3d-cell-culture-market-by-product-hydrogels-ecm-hanging-drop-bioreactor-microfluidics-magnetic-levitation-application-cancer-stem-cell-tissue-engineering-end-user-pharma-biotech-research-region-global-forecast-to-2028","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}